Wells Fargo
BIOA

Wells Fargo’s BioAge Labs BIOA Stock Holding History

Wells Fargo’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$199K Sell
11,406
-15,191
-57% -$293K ﹤0.01% 4704
2025
Q4 		$352K Buy
26,597
+6,709
+34% +$59.5K ﹤0.01% 4726
2025
Q3 		$117K Buy
19,888
+4,665
+31% +$21.8K ﹤0.01% 5241
2025
Q2 		$62.9K Buy
15,223
+8,778
+136% +$35.4K ﹤0.01% 5427
2025
Q1 		$24.2K Buy
6,445
+143
+2% +$661 ﹤0.01% 5648
2024
Q4 		$36.5K Buy
+6,302
New +$109K ﹤0.01% 5581

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Wells Fargo's BIOA Position: Q1 2026 in Review

Wells Fargo reduced its BioAge Labs (BIOA) stake by 57% in Q1 2026, selling an estimated $293K and leaving 11,406 shares worth $199K. The position accounts for ﹤0.01% of the portfolio, ranked #4704.

Wells Fargo first reported a position in BIOA in Q4 2024 and has held it in 6 quarters since. The position peaked at $352K in Q4 2025. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Wells Fargo held 11,406 shares of BioAge Labs worth $199K as of Q1 2026.
  • Wells Fargo sold 15,191 BioAge Labs shares in Q1 2026, an estimated $293K.
  • BioAge Labs made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #4704 holding.
  • Wells Fargo first reported a position in BioAge Labs in Q4 2024 and has held it in 6 quarters since.
  • Wells Fargo's BioAge Labs position peaked at $352K in Q4 2025.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.